Compare Aurora Cannabis Inc (ACB) vs Lithium Americas Corp (LAC) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

Lithium Americas (LAC) trades at $3.82, up 1.6% with a bearish technical signal despite recent earnings beats. The company shows negative profitability with ROE at -11.35% and net income of -$122.09M for 2025, though cash flow from financing surged to $1.14B. Construction milestones at Thacker Pass dominate recent news, with analyst consensus leaning toward Hold (53.33%) versus Buy (46.67%) and a $6.25 price target suggesting 64% upside potential.

Outlook remains speculative with high execution risk on Thacker Pass development requiring $1.3-1.6B in 2026 capex. Government support and lithium demand underpin long-term opportunity, but near-term dilution risk from ATM share issuances and negative cash flow from operations (-$61.22M) pressure equity valuation. Investors face binary outcome: project success drives multi-bag returns, while delays or cost overruns could erode shareholder value further.